COINOTAG News reported on September 11 that U.S.-listed MEI Pharma announced a corporate rebrand to Litecoin Strategy (Nasdaq: LITS), with the company publicly disclosing the name change in its announcement.
During intraday trading the stock was up 10.61%, and the company’s market capitalization was reported at approximately $101 million, based on real-time market data.
Market participants and investors are advised to review the company’s official regulatory disclosures and SEC filings as well as company releases for authoritative details regarding the rebrand and any material corporate developments.